Doctor's Bio
Board Certifications
American Board of Obstetrics and Gynecology
Affiliations
Emory
Education & Training
- Medical School: Emory University School of Medicine
- Internship: Brigham and Women's Hospital
- Residency: Brigham and Women's Hospital
Fellowships
Memorial Sloan Kettering Cancer Center
Locations and Directions
Grady Memorial Hospital
Phone: (404) 616-1000
Location:
80 Jesse Hill Jr Drive SE
Atlanta, GA 30303
Publications
- Risk factors and clinical outcomes of radiation-induced fistula after chemoradiation and image-guided brachytherapy for locally advanced cervical cancer.
Ali N, Sykes Martin KD, Tobillo R, Meiyappan K, McCook-Veal A, Switchenko J, Dresser S, Dilley S, Starbuck KD, Khanna N, Shelton J, Patel A, Eng T, Manning-Geist B, Remick JS
Gynecologic oncology reports. 2025;
PMID: 41282280 - Evaluation of toxicity after radical hysterectomy or trachelectomy and post-operative pelvic intensity-modulated radiation therapy with concurrent chemotherapy for cervical cancer.
Manning-Geist BL, Miller M, Dagher C, Kim SH, Kollmeier M, Sonoda Y, Shuford J, Jewell E, Park K, Friedman C, Leitao MM, Alektiar K, Abu-Rustum NR
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2025;35(12):102712.
PMID: 41218458 - Clinicopathologic Features, Molecular Landscape, and Prognostic Implications of Ovarian Low-grade Serous Tumors with Histologic Transformation.
Chui MH, Kang EY, Kahn RM, Chiang S, Zhou Q, Iasonos A, Manning-Geist B, Selenica P, Da Cruz Paula A, Long Roche K, Weigelt B, Grisham RN
Clinical cancer research : an official journal of the American Association for Cancer Research. 2025;31(14):3084-3095.
PMID: 40327333 - Following the folate receptor: Expanding targeted treatment options in low grade serous ovarian carcinoma.
Thayer EG, Manning-Geist BL
Gynecologic oncology. 2024;
PMID: 39667863 - Raising the bar on collaborative science: the SENECA study and sentinel lymph node mapping.
Manning-Geist BL, Mueller JJ
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2024;34(9):1322-1323.
PMID: 39160084 - Folate receptor alpha expression in low-grade serous ovarian cancer: Exploring new therapeutic possibilities.
Manning-Geist BL, Sullivan MW, Zhou Q, Iasonos A, Selenica P, Stallworth C, Liu YL, Long Roche K, Gordhandas S, Aghajanian C, Chi D, O'Cearbhaill R, Grisham RN, Chui MH
Gynecologic oncology. 2024;
PMID: 38941962 - Endometrial cancer at recurrence: To re-sequence or not to re-sequence.
Fuh K, Manning-Geist BL
Gynecologic oncology reports. 2024;
PMID: 38841264 - Redefining the standard of care for low-grade serous ovarian cancer.
Manning-Geist BL, Cantor T, O'Cearbhaill RE, Grisham RN
Clinical advances in hematology & oncology : H&O. 2024;22(5):205-226.
PMID: 38805312 - Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses.
Friedman CF, Manning-Geist BL, Zhou Q, Soumerai T, Holland A, Da Cruz Paula A, Green H, Ozsoy MA, Iasonos A, Hollmann T, Leitao MM, Mueller JJ, Makker V, Tew WP, O'Cearbhaill RE, Liu YL, Rubinstein MM, Troso-Sandoval T, Lichtman SM, Schram A, Kyi C, Grisham RN, Causa Andrieu P, Wherry EJ, Aghajanian C, Weigelt B, Hensley ML, Zamarin D
Nature medicine. 2024;30(5):1330-1338.
PMID: 38653864 - Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation.
Manning-Geist BL, Rios-Doria E, Liu YL, Ellenson LH, Zhou QC, Iasonos A, Leitao MM, Abu-Rustum NR, Weigelt B, Mueller JJ
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2024;34(5):697-704.
PMID: 38508587
PLANNING
PREPARING FOR YOUR VISIT
Whether you’re a patient or you’re visiting one, a little planning beforehand can make your visit to Grady easier and more comfortable. Here, you’ll find everything you need to prepare for your visit, including an appointment checklist, admissions information, dining options, and much more.